Original ResearchBrief ReportInterleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency
Section snippets
Acknowledgments
Very Early Onset Inflammatory Bowel Disease International Consortium: Dror S. Shouval, Amlan Biswas, Alexandra E. Griffith, Liza Konnikova, Michael Field, Anthony Loizides, Batia Weiss, Baruch Yerushalmi, Tadahiro Yanagi, Aleixo M. Muise, Christoph Klein, Bruce H. Horwitz, Sarah C. Glover, and Athos Bousvaros.
References (17)
Adv Immunol
(2014)- et al.
Gastroenterology
(2012) Immunity
(2014)Immunity
(2014)Mucosal Immunol
(2014)Immunity
(2013)Cell
(2014)Immunity
(2016)
Cited by (148)
Genetic Defects in Early-Onset Inflammatory Bowel Disease
2023, Rheumatic Disease Clinics of North AmericaMathematical models disentangle the role of IL-10 feedbacks in human monocytes upon proinflammatory activation
2023, Journal of Biological ChemistryAntimicrobial overproduction sustains intestinal inflammation by inhibiting Enterococcus colonization
2023, Cell Host and MicrobeMicrobiome-phage interactions in inflammatory bowel disease
2023, Clinical Microbiology and Infection
Conflicts of interest The authors disclose no conflicts.
Funding Dror S. Shouval is a recipient of a Research Fellowship Award Grant from the Crohn’s and Colitis Foundation of America (CCFA). Amlan Biswas is recipient of CCFA Career Development Award and National Institutes of Health (NIH) KO1 award (K01DK109026). Yu Hui Kang is a recipient of an A*STAR National Science Scholarship (Singapore). Scott B. Snapper is supported by NIH Grant DK034854, the Helmsley Charitable Trust, the Translational Investigator Service at Boston Children's Hospital, and the Wolpow Family Chair in IBD Treatment and Research.
Author names in bold designate shared co-first authorship.
- ∗
Authors share co-first authorship.